required; MBA preferred Minimum of 8-10 years of Biotech/Pharma experience Strong US Market Access experience required, in... environment in pharma industry Demonstrated project management skills Consistently delivers high-quality results under tight...
: Doctorate degree OR Master’s degree and 3 years of biotech/pharma-related business operations/financial analytics experience... OR Bachelor’s degree and 5 years of biotech/pharma-related business operations/financial analytics experience OR Associate...
degree in Business, Science, Engineering or related field with 15+ years of experience in global supply chain from pharma..., biotech or cell & gene therapy companies Passion for patients, collaborative and effective leader Advanced knowledge...
on the industries of Pharma, Biotech, Manufacturing QC, Medical Devices, specialty chemicals and other research-based... of relevant technical experience including (but not limited to); biotech/pharmaceutical company or an automation provider...
cell therapy trials. 8+ years clinical operations experience in biotech/pharma including 4+ years as manager and higher...Must be local to the NJ/PA areas. My biotech client is a clinical stage cell therapy company and seeks a Director...
. Zifo is a global R&D solutions provider focused on the industries of Pharma, Biotech, Manufacturing QC, Medical Devices... strategic projects for R&D division at pharmaceutical and biotech customers. The individual will gather business requirements...
Presenting a comprehensive recap of the week's highlights, spanning from top news to market performance, here's your market wrap for the week concluding on June 28, 2024. Continue Reading »
Indian stock market benchmarks—the Nifty 50 and the Sensex— ended the first half of the current calendar year with healthy gains, rising 10.5 per cent and 9.4 per cent, respectively. Continue Reading »
This initiative coincides with India’s inclusion in JPMorgan’s emerging market bond index on Friday. This inclusion is anticipated to attract an inflow of $20 billion to $25 billion over the next 10 months, as estimated by JPMorgan Continue Reading »
According to a report by Geojit, during the rally from 23,264 points to 24,041 points, the top five stocks are estimated to have contributed nearly 71% to the index's gains. In contrast, the bottom five stocks exerted a drag of approximately 27% on the index's performance during this period Continue Reading »
Nifty 50 index journey from 1,000 to 24,000 marked by rapid milestones and consistent growth, reaching 24,000 on June 27, 2024, with a remarkable 1,000-point rally in 0.8 months. Market cap increased by ₹12.2 lakh crore during this period, reflecting market dynamism and investor opportunities. Continue Reading »
Latest Market News Today Live Updates: Follow Mint's market blog for real-time updates on your favourite companies. This blog keeps you informed on all things Dalal Street and global markets. Continue Reading »
With concerns of political and economic stability allayed, the upcoming Union budget and corporate earnings are expected to be the next big triggers for foreign investors in Indian equities Continue Reading »